Loading...
Biomarkers in prostate cancer surveillance and screening: past, present, and future
The use of biomarkers for prostate cancer (PCa) screening, detection, and prognostication have revolutionized the diagnosis and management of the disease. Current clinical practice has been driven largely by the utilization of prostate-specific antigen (PSA). The lack of specificity of PSA for PCa h...
Saved in:
Main Authors: | , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
SAGE Publishing
2013-12-01
|
Series: | Therapeutic Advances in Urology |
Online Access: | https://doi.org/10.1177/1756287213495915 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|